SED5 Antibody

What is SED5/Syntaxin 5 and what cellular functions does it regulate?

SED5 (in yeast) or Syntaxin 5 (STX5, in mammals) is a t-SNARE protein that plays critical roles in vesicular transport. In mammalian cells, Syntaxin 5 exists in two main forms: a 37 kDa form localized to the cis-Golgi network and a 46 kDa form embedded in the endoplasmic reticulum (ER). This protein is widely expressed in most tissues, with notably lower expression in striated muscle. Functionally, Syntaxin 5 is involved in the regeneration and maintenance of the Golgi apparatus after mitosis and mediates ER-Golgi and intra-Golgi vesicular transport .

Human Syntaxin 5 is a type IV single-pass transmembrane protein with a very long cytoplasmic N-terminus, spanning 355 amino acids in length. Its structure includes an ER retrieval signal (Arg4Lys5Arg6), a t-SNARE domain (amino acids 263-325) with a coiled-coil region (amino acids 287-318), and a C-terminal transmembrane sequence. The shorter 35 kDa form results from an alternate start site at Met55 .

What detection methods work best with SED5/Syntaxin 5 antibodies?

SED5/Syntaxin 5 antibodies have been successfully employed in multiple detection methods, with each offering distinct advantages depending on the research question:

• Western Blot: Effectively detects specific Syntaxin 5 bands at approximately 35 and 42 kDa in human cell lysates (including T47D breast cancer and Raji Burkitt's lymphoma cell lines) under reducing conditions. This method is ideal for determining protein expression levels and confirming antibody specificity .

• Immunocytochemistry (ICC): SED5/Syntaxin 5 antibodies work well for localizing the protein in fixed cells, such as SH-SY5Y human neuroblastoma cells, where specific staining is observed in the cytoplasm. This approach is valuable for studying subcellular localization .

• Immunohistochemistry (IHC): Both chromogenic and fluorescent IHC have been successful in detecting Syntaxin 5 in tissue sections, including human brain (substantia nigra) and rat brain, with specific staining localized to neuronal cytoplasm .

• Simple Western™: This automated capillary-based immunoassay has detected specific Syntaxin 5 bands at approximately 39 and 47 kDa in human cell line lysates, offering a quantitative alternative to traditional Western blotting .

How should SED5/Syntaxin 5 antibodies be stored and handled for optimal results?

For optimal antibody performance and longevity, follow these storage and handling recommendations:

• Use a manual defrost freezer and avoid repeated freeze-thaw cycles which can degrade antibody quality.

• Long-term storage: Store at -20°C to -70°C for up to 12 months from date of receipt in the supplied format.

• Short-term storage: After reconstitution, the antibody remains stable for 1 month at 2-8°C under sterile conditions.

• Medium-term storage: Reconstituted antibody can be stored for 6 months at -20°C to -70°C under sterile conditions.

• When working with the antibody, maintain sterile techniques to prevent contamination .

How can SED5/Syntaxin 5 antibodies be used to study autophagy mechanisms?

SED5/Syntaxin 5 has been implicated in autophagy pathways, and specific antibodies can help elucidate these mechanisms:

Recent research has demonstrated that Sed5 is involved in both the cytoplasm-to-vacuole targeting (Cvt) pathway and starvation-induced autophagy. In experimental systems, sed5-1 mutant cells show impaired transport of Atg8 (a key autophagy marker) to the pre-autophagosomal structure (PAS), resulting in multiple Atg8 dots dispersed throughout the cytoplasm with some trapped in the Golgi apparatus .

To study these mechanisms, researchers can:

• Use SED5 antibodies in co-localization studies with autophagy markers like Atg8/LC3 to visualize trafficking defects.

• Combine SED5 antibodies with mutant expression (e.g., sed5-1) to track changes in protein localization and interaction.

• Employ these antibodies in immunoprecipitation experiments to identify protein complexes involved in autophagosome formation.

The role of Sed5 in regulating the anterograde trafficking of Atg9-containing vesicles to the PAS by participating in the localization of Atg23 and Atg27 to the Golgi apparatus provides important research targets for SED5 antibody applications .

What considerations are important when using SED5/Syntaxin 5 antibodies for phosphorylation studies?

When investigating SED5/Syntaxin 5 phosphorylation states, researchers should consider:

• Phosphospecific antibodies: While standard SED5 antibodies detect total protein, phosphospecific antibodies might be needed to distinguish between phosphorylated and non-phosphorylated forms, particularly at the critical serine-317 residue which is a PKA phosphorylation site .

• Sample preparation: Phosphatase inhibitors should be included during protein extraction to preserve phosphorylation states.

• Controls: Include phosphatase-treated samples as negative controls and samples from cells with activated PKA as positive controls.

• Complementary techniques: Combine antibody-based detection with mass spectrometry to confirm phosphorylation sites.

Research has shown that Sed5 phosphorylation status significantly impacts Golgi morphology and function. Mutation of serine-317 to alanine (mimicking a non-phosphorylated state) results in an atypical ordered Golgi structure in yeast, while mutation to aspartate (mimicking phosphorylation) causes accumulation of ER and transport vesicles and inhibits cell growth .

How can researchers address cross-reactivity concerns with SED5/Syntaxin 5 antibodies?

Cross-reactivity is a critical consideration when selecting antibodies for specific experimental applications. For SED5/Syntaxin 5 antibodies:

• Validation testing: Confirm specificity through direct ELISAs with recombinant proteins. For example, antibodies like AF5687 have demonstrated less than 1% cross-reactivity with related proteins such as recombinant human Syntaxin 7 .

• Knockout/knockdown controls: Include samples from cells where SED5/Syntaxin 5 has been depleted to verify antibody specificity.

• Multiple antibody approach: Use antibodies recognizing different epitopes of SED5/Syntaxin 5 to confirm results.

• Species considerations: Check sequence homology across species when using antibodies across model organisms. For example, human and mouse Syntaxin 5 share 94% amino acid identity over residues 55-300, suggesting good cross-species reactivity for antibodies targeting this region .

What are common challenges in detecting SED5/Syntaxin 5 and how can they be overcome?

Researchers often encounter several challenges when working with SED5/Syntaxin 5 antibodies:

• Multiple isoforms: Syntaxin 5 exists in different forms (35-46 kDa) due to alternative start sites and splice variants. Researchers should be aware of which isoforms their antibody detects and optimize protocols accordingly. For example, the longer 46 kDa form is predominantly found in the ER, while the 37 kDa form localizes to the cis-Golgi .

• Low signal intensity: For weak signals in Western blots, consider:

  • Increasing antibody concentration (optimal dilutions should be determined for each application)

  • Extending incubation time

  • Using enhanced detection systems

  • Enriching for membrane fractions during sample preparation

• Background in immunostaining: To reduce background:

  • Increase blocking time/concentration

  • Optimize antibody dilution

  • Include additional washing steps

  • Use appropriate negative controls

• Cell/tissue-specific expression: Expression levels vary across tissues, with notable absence in striated muscle. Ensure your experimental model expresses SED5/Syntaxin 5 at detectable levels .

How can researchers effectively design SED5/Syntaxin 5 mutation studies?

When designing mutation studies to investigate SED5/Syntaxin 5 function:

• Target key functional domains:

  • The t-SNARE domain (amino acids 263-325)

  • The coiled-coil region (amino acids 287-318)

  • The PKA phosphorylation site at serine-317

  • The ER retrieval signal (Arg4Lys5Arg6)

• Consider substitution strategies:

  • For phosphorylation studies, use alanine substitutions to prevent phosphorylation and aspartate/glutamate substitutions to mimic constitutive phosphorylation

  • For transmembrane domains, consider hydrophobicity-preserving substitutions

• Expression systems:

  • In yeast, plasmids with different copy numbers (single-copy CEN plasmids vs. multi-copy 2μ plasmids) can help control expression levels

  • Consider inducible promoters to regulate mutant protein expression

• Complementation analysis:

  • Test if mutant versions can rescue phenotypes in SED5-depleted cells

  • Combine with temperature-sensitive alleles (e.g., sed5-1) for conditional studies

Research has demonstrated the dramatic effects of serine-317 substitutions on Golgi morphology and function, highlighting the importance of this residue in controlling SED5 activity .

How can SED5/Syntaxin 5 antibodies be used to study the relationship between Golgi structure and autophagy?

Recent findings have revealed important connections between Golgi function and autophagy that can be explored using SED5/Syntaxin 5 antibodies:

• Co-localization studies: Use SED5 antibodies together with autophagy markers (Atg8/LC3, Atg9) to track their distribution in normal and autophagy-inducing conditions (e.g., starvation). This can reveal how Golgi-derived membranes contribute to autophagosome formation.

• Mutant analysis: Compare wild-type cells with sed5-1 mutants to investigate how Golgi disruption impacts autophagy. Research has shown that sed5-1 mutants exhibit defects in both the Cvt pathway and starvation-induced autophagy .

• Suppressor screening: SED5 antibodies can help validate genetic interactions identified through suppressor screens. For example, overexpression of SFT1 or SFT2 (suppressors of sed5 ts) has been shown to rescue autophagy defects in sed5-1 mutant cells, suggesting functional relationships that can be confirmed at the protein level .

• Vesicle tracking: Since Sed5 regulates anterograde trafficking of Atg9-containing vesicles to the PAS, antibodies can help visualize this process and identify defects in transport pathways.

These approaches can help elucidate the fundamental mechanisms linking Golgi function to autophagosome formation and maturation .

What techniques can be combined with SED5/Syntaxin 5 antibodies for comprehensive analysis of membrane trafficking?

For a multi-faceted analysis of membrane trafficking involving SED5/Syntaxin 5:

• Live-cell imaging with fixed-cell correlative microscopy:

  • Track GFP-tagged proteins in living cells

  • Fix cells at specific timepoints

  • Use SED5/Syntaxin 5 antibodies for immunostaining

  • Correlate live dynamics with fixed protein localization

• Immuno-electron microscopy:

  • Use SED5 antibodies with gold-conjugated secondary antibodies

  • Visualize the ultrastructural localization of Syntaxin 5

  • Particularly useful for examining Golgi morphology changes in mutant cells (e.g., S317A mutants that show atypical ordered Golgi structures)

• Proximity labeling techniques:

  • Combine with BioID or APEX2 approaches to identify proteins in proximity to SED5/Syntaxin 5

  • Validate interactions using co-immunoprecipitation with SED5 antibodies

• Super-resolution microscopy:

  • Use fluorescently-labeled SED5 antibodies with techniques like STORM or STED

  • Resolve sub-Golgi localization beyond the diffraction limit

  • Compare localization in different mutant backgrounds

• Mass spectrometry of immunoprecipitated complexes:

  • Pull down SED5/Syntaxin 5 and associated proteins

  • Identify interaction partners and post-translational modifications

  • Compare complexes under different conditions (e.g., starvation, ER stress)

How do mutations in SED5/Syntaxin 5 impact experimental design when using antibodies?

When working with SED5/Syntaxin 5 mutants, several considerations for antibody-based experiments include:

• Epitope accessibility: Mutations may alter protein folding or complex formation, potentially affecting antibody recognition. Researchers should:

  • Verify antibody reactivity with each mutant form

  • Consider antibodies targeting different epitopes

  • Include controls to confirm expression of mutant proteins (e.g., epitope tags)

• Localization changes: Mutations can dramatically alter SED5/Syntaxin 5 localization. For example:

  • S317A (non-phosphorylatable) mutants localize to atypical ordered Golgi structures

  • S317D (phosphomimetic) mutants show accumulation in ER and transport vesicles

  Immunostaining protocols may need optimization to effectively visualize these different patterns.

• Protein stability: Some mutations may affect protein stability, requiring:

  • Careful timing of experiments after expression

  • Proteasome inhibitors to prevent degradation

  • Quantitative Western blotting to assess expression levels

• Functional readouts: When studying mutant phenotypes:

  • Combine antibody detection with functional assays (e.g., trafficking of model cargo proteins)

  • Use time-course experiments to distinguish primary from secondary effects

  • Consider temperature-sensitive mutants for conditional studies

These considerations will ensure more robust interpretations when investigating the molecular mechanisms through which SED5/Syntaxin 5 phosphorylation controls Golgi morphology and function .

How should researchers interpret conflicting results between different detection methods for SED5/Syntaxin 5?

When faced with conflicting results across different detection methods:

• Consider method-specific limitations:

  • Western blotting detects denatured proteins, potentially missing conformational epitopes

  • Immunostaining preserves spatial information but may have fixation artifacts

  • Native conditions in immunoprecipitation maintain protein interactions but may mask epitopes

• Analyze isoform detection:

  • Different methods may preferentially detect certain Syntaxin 5 isoforms

  • The 35 kDa form (alternate start at Met55) may show different patterns than the full-length 46 kDa form

  • Additional splice variants with Met97 start sites coupled to amino acid substitutions may be recognized differently

• Cross-validate with multiple antibodies and approaches:

  • Use antibodies targeting different epitopes

  • Combine with tagged versions (GFP, HA) for orthogonal detection

  • Apply complementary techniques (e.g., mass spectrometry)

• Consider cellular context:

  • Cell type-specific differences in post-translational modifications

  • Variations in binding partners that might mask epitopes

  • Differences in subcellular localization between experimental systems

By systematically addressing these factors, researchers can reconcile seemingly contradictory results and develop more complete models of SED5/Syntaxin 5 function.

What bioinformatic approaches can complement antibody-based studies of SED5/Syntaxin 5?

To strengthen antibody-based research on SED5/Syntaxin 5, integrate these bioinformatic approaches:

• Sequence conservation analysis:

  • Align SED5/Syntaxin 5 sequences across species

  • Identify highly conserved regions likely to be functionally important

  • Note that human and mouse Syntaxin 5 share 94% amino acid identity over residues 55-300, suggesting evolutionary importance of this region

• Structural prediction and modeling:

  • Generate 3D structural models of SED5/Syntaxin 5 domains

  • Predict effects of mutations on protein folding and interactions

  • Visualize potential epitopes for antibody recognition

• Interaction network analysis:

  • Integrate SED5/Syntaxin 5 into protein-protein interaction networks

  • Identify key partners for co-immunoprecipitation validation

  • Predict functional modules that might be disrupted in mutants

• Phosphorylation site prediction:

  • Use algorithms to identify potential phosphorylation sites beyond the known serine-317

  • Predict kinases that might target these sites

  • Design experiments to test predictions using phospho-specific antibodies

• Expression correlation analysis:

  • Analyze transcriptomic datasets for genes co-regulated with SED5/Syntaxin 5

  • Identify potential functional relationships for experimental validation

  • Compare expression patterns across tissues and conditions

These computational approaches provide valuable context for interpreting antibody-based findings and can guide the design of targeted experiments to test specific hypotheses about SED5/Syntaxin 5 function.

How can SED5/Syntaxin 5 antibodies contribute to understanding neurodegenerative disease mechanisms?

SED5/Syntaxin 5 antibodies offer valuable tools for investigating potential connections to neurodegenerative diseases:

• Neuronal localization studies: Syntaxin 5 has been detected in neuronal cytoplasm in both human substantia nigra and rat brain sections . This localization in regions affected by neurodegenerative diseases (particularly Parkinson's disease) suggests potential disease relevance that can be further explored using specific antibodies.

• Autophagy dysfunction in neurodegeneration: Given that Sed5 regulates autophagy and autophagy defects are implicated in multiple neurodegenerative diseases, SED5 antibodies can help investigate whether altered Syntaxin 5 function contributes to disease-associated autophagy impairment.

• Golgi fragmentation studies: Golgi fragmentation is a common feature in neurodegenerative conditions including Alzheimer's, Parkinson's, and ALS. Since Sed5 phosphorylation status dramatically affects Golgi morphology , antibodies detecting total and phosphorylated Syntaxin 5 can help determine whether altered phosphorylation contributes to pathological Golgi fragmentation.

• Protein trafficking defects: Many neurodegenerative diseases involve protein trafficking abnormalities. SED5 antibodies can help assess whether Syntaxin 5 dysfunction contributes to mislocalization of disease-relevant proteins like APP, α-synuclein, or TDP-43.

Research using these approaches could reveal whether targeting Syntaxin 5 or its regulatory pathways represents a potential therapeutic strategy for neurodegenerative disorders.

What are the latest methodological advances in applying SED5/Syntaxin 5 antibodies to study cellular stress responses?

Recent methodological innovations for studying SED5/Syntaxin 5 in cellular stress responses include:

• Stress-inducible systems: Combining SED5 antibodies with cellular stress models (ER stress, oxidative stress, nutrient deprivation) to track dynamic changes in Syntaxin 5 localization, phosphorylation, and interaction partners.

• Quantitative multiplexed imaging:

  • Multiplex immunofluorescence with automated image analysis

  • Simultaneous detection of SED5/Syntaxin 5 alongside stress markers and other SNARE proteins

  • Spatial relationship analysis between Syntaxin 5 and stress-induced compartments

• Proximity labeling under stress conditions:

  • BioID or APEX2 fusions to SED5/Syntaxin 5 activated during specific stress conditions

  • Mass spectrometry identification of stress-specific interaction partners

  • Validation of hits using co-immunoprecipitation with SED5 antibodies

• Phosphoproteomics integration:

  • Global phosphoproteomic analysis during stress responses

  • Identification of stress-induced changes in Syntaxin 5 phosphorylation beyond the known serine-317 site

  • Correlation with functional outcomes using SED5 antibodies

These approaches can help reveal how Syntaxin 5 function is modulated during stress conditions and how these changes impact cellular adaptation or pathology, particularly given the dramatic effects of phosphorylation state on Golgi morphology and function .